SCHEMBL15324640

SCHEMBL15324640

CNC1CCc2ccc(OCCN)cc2C1Cc1ccccc1F

nearest known ligand 0.52

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 13/20 0.52
SCN3A Q9NY46 3/20 0.40
KCNH2 Q12809 4/20 0.37
MAOB P27338 1/20 0.35
NQO2 P16083 1/20 0.34
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3105956 0.99 SLC6A9 (0.51) SLC6A9SCN3AKCNH2MAOBNQO2
SCHEMBL15323988 0.89 SLC6A9 (0.51) SLC6A9
Hydrochloric Acid SCHEMBL3098707 0.88 SLC6A9 (0.51) SLC6A9
SCHEMBL15324638 0.86 SCN3A (0.48) SLC6A9SCN3AKCNH2MAOB
Hydrochloric Acid SCHEMBL3105949 0.85 SCN3A (0.47) SLC6A9SCN3AKCNH2MAOB
SCHEMBL7894080 0.83 SLC6A9 (0.63) SLC6A9KCNH2NQO2MTNR1AMTNR1B
SCHEMBL7894596 0.83 SLC6A9 (0.79) SLC6A9KCNH2
Hydrochloric Acid SCHEMBL3093981 0.82 SLC6A9 (0.77) SLC6A9KCNH2
SCHEMBL15324231 0.78 SLC6A9 (0.48) SLC6A9KCNH2MAOBNQO2MTNR1A
SCHEMBL15323987 0.75 SLC6A9 (0.47) SLC6A9SCN3ANQO2MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2396296-B1 AMINOTETRALINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY ABBVIE DEUTSCHLAND (DE) 2016-05-25 EP claimed
US-9067871-B2 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG (DE) 2015-06-30 US claimed
US-8563617-B2 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG (DE) 2013-10-22 US claimed